Year: 2020

news_6

TROPION-Lung01 Head-to-Head Phase 3 Trial Initiated to Evaluate Datopotamab Deruxtecan Versus Docetaxel in Previously Treated Patients with Advanced or Metastatic NSCLC Without Actionable Genomic Alterations

TOKYO & MUNICH & BASKING RIDGE, N.J.--(BUSINESS WIRE)--Daiichi Sankyo Company, Limited (hereafter, Daiichi Sankyo) and AstraZeneca today announced the initiation...

news_6

TROPION-Lung05 Phase 2 Trial of Datopotamab Deruxtecan Initiated in Patients with Advanced or Metastatic NSCLC with Actionable Genomic Alterations

TOKYO & MUNICH & BASKING RIDGE, N.J.--(BUSINESS WIRE)--Daiichi Sankyo Company, Limited (hereafter, Daiichi Sankyo) and AstraZeneca today announced the initiation...

news_6

ADC Therapeutics and Overland Pharmaceuticals Announce Formation of Overland ADCT BioPharma to Develop and Commercialize Lonca and other ADCs for Hematologic and Solid Tumor Indications in Greater China and Singapore

- Hillhouse-backed Overland Pharmaceuticals to initially contribute $50 million to fund operations and development LAUSANNE, Switzerland & SHANGHAI & BOSTON--(BUSINESS...

news_6

Travel Services Market to Grow by $ 56 Billion in India During 2020-2024 | Domestic Flight Services Segment to Present Significant Opportunities | Technavio

LONDON--(BUSINESS WIRE)--#India--Technavio has been monitoring the travel services market and it is poised to grow by USD 56 billion during...